FDA NDC Directory · JSON-LD · Markdown

Tranexamic Acid

NDC 63323-563 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA091596
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsTRANEXAMIC ACID (100 mg/mL)
Marketing started20120524
Package count1

External sources

Source: openFDA. Public-domain (CC0).